Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
04/2012
04/10/2012US8152861 Dark coloured azo dyes
04/10/2012CA2612976C Amide derivative and insecticide containing the same
04/05/2012WO2012045007A1 Method of preparation of (4 - {4 -acetylamino- 2 - [3- ( 2 - isopropyl - thiazol - 4 - ylmethyl) - 3 -methyl - ureido] - butyryl amino} -1 -benzyl- 5 -phenyl- pentyl) -carbamic acid thiazol - 5 - ylmethyl ester
04/05/2012WO2012041253A1 Compounds for increase of hdl-c level and uses thereof
04/05/2012WO2012020272A3 New salts, polymorphs and solvates of febuxostat
04/05/2012WO2011133719A3 Anti-viral compounds
04/05/2012US20120083608 Process for the preparation of [4-(2-chloro-4- methoxy-5-methylphenyl)-5-methyl-thiazolo-2-yl]-[2-cyclopropyl-1-(3-fluoro-4-methylphenyl)-ethyl]-amine
04/05/2012US20120083490 Cytochrome p450 oxidase inhibitors and uses thereof
04/04/2012EP2436687A1 Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof
04/04/2012EP2435404A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
04/04/2012EP1914225B1 Display device comprising salt molten at room temperature
04/04/2012EP1893583B1 Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists
04/04/2012EP1583529B9 Amino acid phenoxy ethers, their preparation and uses
04/04/2012CN101328156B 含1,3二杂五元环的异羟肟酸类衍生物及其用途 Containing 1,3 hetero five-membered ring hydroxamic acid derivatives and their use
04/03/2012US8148542 Method for producing crystal polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid
04/03/2012US8148541 Rhodanine derivatives, a process for the preparation thereof and pharmaceutical composition containing the same
04/03/2012US8148539 Cyanine dye labelling reagents
04/03/2012US8148533 Ionic liquids having melting points below about 100 C formed by reaction of a heterocyclic amine with about 2.8 and about 3.2 moles of anhydrous hydrogen fluoride per mole of amine nitrogen. Electrochemical devices having nonaqueous electrolytes containing the ionic liquids are disclosed and sio2 etch
04/03/2012US8148412 e.g. {-[3-Cyclopentyl-2-(4-methane sulfonyl-phenyl)-propionylamino]-5-methyl-thiazol-4-yl}-acetic acid ethyl ester; antidiabetic and hypoglycemic agent; non-insulin dependent diabetis, obesity, impaired glucose tolerance, eating disorder, dyslipidemia, hyperlipidemia, hypertension
04/03/2012US8148411 2-hetarylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals
04/03/2012US8148380 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds
04/03/2012CA2566464C Synthesis of tetracyclines and analogues thereof
04/03/2012CA2505427C Bicyclic-substituted amines as histamine-3 receptor ligands
04/03/2012CA2493329C Releasable polymeric conjugates based on aliphatic biodegradable linkers
03/2012
03/29/2012WO2012039460A1 Substituted amide compound
03/29/2012US20120077975 Human protein tyrosine phosphatase inhibitors and method of use
03/29/2012US20120077855 Crystalline tripeptide epoxy ketone protease inhibitors
03/29/2012US20120077854 Compositions and methods for modulating retinol binding to retinol binding protein 4 (rbp4)
03/29/2012US20120077806 Deubiquitinase Inhibitors and Methods for Use of the Same
03/29/2012CA2810706A1 Substituted amide compound
03/28/2012EP2432760A1 Bridged spiro [2.4]heptane derivatives as alx receptor and/or fprl2 agonists
03/28/2012EP1951690B1 Heterocyclic cetp inhibitors
03/28/2012CN102391262A Antimicrobial compound containing 3-carboxyalkyl rhodanine derivative
03/28/2012CN102391222A Novel hydroxamates as therapeutic agents
03/28/2012CN102391207A N-(2-(substituted benzo- thiazole-2- amino formacyl) -phenyl group) - benzamide, as well as preparation method and usages thereof
03/28/2012CN102391206A Method for producing rubber vulcanization accelerator DZ
03/28/2012CN102391205A Method for synthesizing rubber vulcanization accelerant 2-mercaptobenzothiazole
03/28/2012CN102391204A Chiral 2,4-disubstituted-thaizolidinone compounds and preparation method and application thereof in preparation of anticancer medicaments
03/28/2012CN102391203A Intermediate of 6-substituted-1-methyl-1-h-benzimidazole derivative and method for producing same
03/28/2012CN101759665B Substituent phenylpiperazine aryl alkanol derivant and application thereof in preparing analgesics
03/28/2012CN101218237B Oxime derivative and preparations thereof
03/27/2012US8143415 Processes for making epothilone compounds and analogs
03/27/2012US8143296 Thiazole-based compound and inhibitor of T-type calcium channel containing the same
03/27/2012US8143261 Thiazolo (4,5-D) pyrimidine compounds
03/27/2012US8143258 Benzothiazole compounds useful for Raf inhibition
03/27/2012US8143242 Malonamide derivatives with antithrombotic activity
03/22/2012WO2012036974A1 Novel thiazol-carboximide derivatives as pdk1 inhibitors
03/22/2012WO2012036151A1 Sulfur amino acid-producing bacteria and method for producing sulfur amino acids
03/22/2012WO2012035990A1 Charge control agent and toner using same
03/22/2012US20120071524 Compounds for treatment of cancer
03/22/2012US20120071516 Compounds that modulate intracellular calcium
03/22/2012US20120071513 Compositions and Their Use as Anti-Tumor Agents
03/22/2012US20120071475 Urea derivatives having pi3k-inhibiting activity
03/21/2012EP2430006A1 Cyclopenta[c]pyrrole-2-carboxylate derivatives, preparation thereof, and therapeutic use thereof
03/21/2012EP2429998A1 5-membered heterocyclic compound cyclopenta[c]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof
03/21/2012EP2429523A1 Thiazolidin-4-one and [1,3]-thiazinan-4-one compounds as orexin receptor antagonists
03/21/2012EP2188254B1 Novel bradykinin b1-antagonists
03/21/2012CN1989115B Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses
03/21/2012CN1984895B Synthesis and uses of synephrine derivatives
03/21/2012CN102388029A Derivatives of 6-(6-o-cycloalkyl or 6-nh-cycloalkyl-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
03/21/2012CN102388022A Hydrazide compound and use of the same in pest control
03/21/2012CN102382077A Method for preparing pharmaceutical grade DM (accelerator) with industrial grade DM
03/21/2012CN102382076A Arone and arylamide compound and preparation method and medicine use thereof
03/21/2012CN102380404A Catalyst used for producing promoter N-cyclohexyl benzothiazole sulfonamide and its preparation method
03/21/2012CN102379872A Compounds, compositions and methods of inhibiting a-synuclein toxicity
03/21/2012CN101812035B 2-(3-cyano-4-isobutoxy phenyl)-4-methyl-5-thiazole formic acid crystal forms and preparation method thereof
03/21/2012CN101717378B Method for synthesizing rubber vulcanization accelerator DM by oxygen oxidization
03/21/2012CN101687800B Glucokinase activator
03/21/2012CN101035795B Thiazolyl-dihydro indazoles
03/20/2012US8138210 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
03/20/2012US8138185 Urea glucokinase activators
03/20/2012US8138182 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
03/20/2012CA2636324C Cycloalkylamines as monoamine reuptake inhibitors
03/20/2012CA2472711C 2-acylaminothiazole derivative or salt thereof
03/15/2012WO2012032528A2 Improved process to prepare ethyl 4-methyl-2-(4-(2-methylpropyloxy)-3-cyanophenyl)-5-thiazolecarboxylate
03/15/2012WO2012012307A9 Sulfonyl compounds which modulate the cb2 receptor
03/15/2012WO2011139886A3 Preparation of febuxostat
03/15/2012US20120065247 Modulating ires-mediated translation
03/15/2012US20120065206 Compounds for treating proliferative disorders
03/15/2012US20120065062 Novel Heterocyclic Alkanol Derivatives
03/15/2012US20120064032 Novel hydroxamates as therapeutic agents
03/14/2012EP2427441A1 Pmk2 modulators for use in the treatment of cancer
03/14/2012EP1948627B1 Novel dual peptidase inhibitors as prodrugs for the therapy of inflammatory and other disorders
03/14/2012CN102378759A Derivatives of 6-(6-o-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
03/14/2012CN102372713A Dual alanyl-aminopeptidase and dipeptidyl-peptidase iv inhibitors
03/14/2012CN102372680A Method for preparing 4-thiazolecarboxylic acid
03/14/2012CN102372679A Febuxostat water-soluble derivative and preparation method thereof
03/13/2012US8134010 4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenylamine; N-{4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenyl}-acetamide; or4-Methyl-5-(2-nitrooxy-ethyl)-2-(4-nitro-phenyl)-thiazole; cardiovascular, gastrointestinal, inflammatory, respiratory disease
03/13/2012US8133911 (R)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them
03/13/2012CA2524366C Benzothiazole derivatives as adenosine receptor ligands
03/08/2012WO2012031298A2 Ethynylbenzene derivatives
03/08/2012WO2012029942A1 Cyclic amide derivative
03/08/2012WO2012029672A1 Noxious organism control agent
03/08/2012WO2012028757A1 Fluorinated thiazoles for use in treating cancer
03/08/2012WO2012028582A1 Herbicidally active ketosultams and diketopyridines
03/08/2012WO2012028100A1 Novel compounds
03/08/2012WO2012027965A1 Novel compounds
03/08/2012WO2012000608A3 Novel beta-aminoaldehyde derivatives, process for their preparation and their chemical use as reactive intermediates
03/08/2012WO2011161245A3 Polymorphs of febuxostat
03/08/2012US20120059007 Pharmacologically-active vanilloid carbamates
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 337